MyoKardia, which includes Founders Leslie Leinwand and Christine Seidman, Raises $38 Million in Series A Financing.

MyoKardia, whose founders include Leslie Leinwand, PhD, Professor of Molecular, Cellular and Developmental Biology at the University of Colorado (pictured left), and Christine Seidman, MD, Professor of Medicine and Genetics, Harvard Medical School, and Director of Cardiovascular Genetics Center at Brigham and Women's Hospital (pictured right), launched with a $38 million Series A Financing from Third Rock Ventures LLC. MyoKardia is developing a pipeline of small molecule therapeutics. Read more in the company announcement.